Related Experiment Video
Updated: Aug 3, 2025
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.1K
Intravenous Thrombolysis for Acute Ischemic Stroke.
Continuum (Minneapolis, Minn.)
|April 11, 2023
Summary
Intravenous thrombolysis is a common stroke treatment, but its use is impacted by factor Xa inhibitors and disparities. Advances in speed and imaging improve efficacy, yet implementation challenges persist.
Area of Science:
- Neurology
- Cardiovascular Research
- Public Health
Background:
- Intravenous thrombolysis (IVT) is the primary treatment for acute ischemic stroke.
- Factor Xa inhibitor use complicates IVT eligibility, and significant disparities exist in its implementation.
- The "time is brain" and "tissue clock" concepts guide treatment windows, with mobile stroke units showing promise.
Approach:
- Review of historical context, current indications, and implementation of IVT.
- Analysis of the impact of endovascular thrombectomy and newer agents like tenecteplase.
- Examination of care system models, including "drip and ship" vs. direct transfer.
Key Points:
- IVT efficacy is enhanced by faster treatment and advanced imaging, expanding its application.
- Tenecteplase is emerging as a viable alternative to alteplase due to efficacy and dosing convenience.
- Overcoming disparities in access and implementation remains a critical challenge for equitable stroke care.
Conclusions:
- Despite challenges, IVT remains crucial for acute stroke management.
- Continued research into newer thrombolytics and combination therapies is ongoing.
- Addressing disparities and optimizing care pathways are essential for improving stroke outcomes.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
16
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
16
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
783
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
783
01:28Acute Coronary Syndrome IV: Interprofessional Care
17
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
01:30Venous Thrombosis IV: Nursing Management
18
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
18